A specific small-molecule inhibitor of DAPK1 (IC50 = 13 μM) is an alkylated 3-amino-6-phenylpyridazine that is known to significantly attenuate brain damage after ischemic stroke [130,131]. Here, DAPK1 is linked to ischemic stroke.